Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
ARTIGO
Inglês
Agradecimentos: We thank Maria Jania Teixeira from Universidade Federal do Ceará for providing the MHOM/BR/1994/H3227 strain. This work was supported by grants 2011/20484-7 and 2015/09080-2, São Paulo Research Foundation (FAPESP), grant 473343/2012-6, Conselho Nacional d
Leishmania (Viannia) braziliensis is the main causative species of tegumentary leishmaniasis in Brazil. In this study, we evaluated the susceptibility of 16 clinical isolates of L. (V.) braziliensis from different regions of Brazil to miltefosine in vitro
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
473343/2012-6
COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP
2011/20484-7; 2015/09080-2; 2015/09080-2
fechado
Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
Susceptibility to miltefosine in brazilian clinical isolates of Leishmania (Viannia) braziliensis
Fontes
American journal of tropical medicine and hygiene Vol. 96, no. 3 (2017), p. 656-659 |